Bluefish Pharmaceutical wins Tender Auction in Spain

Once again Bluefish Pharma has been awarded an important number of products in the 12th tender from Andalusian Health authorities. The products to be supplied over the next couple of years will certainly help Bluefish pursuing the goal of making quality treatments accessible to more and more patients. Bluefish is committed to do its best to be able to live up to the Award we just recently received from AIFA  being awarded for the best generic retail launch in Spain in 2017.

Bluefish has successfully built market share in Spain by offering high quality generic pharmaceuticals and never compomising on product quality and patient safety.

 

For more information, contact:

Berit Lindholm, CEO Bluefish Pharmaceuticals 

Tel. +46 8 519 116 00

Email: berit.lindholm@bluefishpharma.com

 

About Bluefish Pharmaceuticals
Bluefish has undergone significant international expansion since the company was founded in 2005. Bluefish focuses on the development, manufacture and sale of generic pharmaceuticals. The company conducts marketing operations in a large number of European markets and is expanding into territories outside Europe. The product portfolio consists of a total of approximately 80 products and is growing.

www.bluefishpharma.com

About Us

Bluefish has undergone significant international expansion since the company was founded in 2005. Bluefish focuses on the development, manufacture and sale of generic pharmaceuticals. The company conducts marketing operations in a large number of European markets and is expanding into territories outside Europe. The product portfolio consists of a total of 80 products and is growing. The company is owned by its founder Karl Karlsson, together with a number of investment funds and private investors.

Subscribe